Analysis of biogenic volatile organic compounds in human health and disease |
| |
Authors: | Jack Dummer Malina Storer Maureen SwanneyMurray McEwan Amy Scott-ThomasShrawan Bhandari Stephen ChambersRaed Dweik Michael Epton |
| |
Institution: | a Respiratory Services, Christchurch Hospital, Christchurch, New Zealand b Department of Medicine, University of Otago, Christchurch, New Zealand c Syft Technologies Ltd, 3 Craft Place, Middleton, Christchurch, New Zealand d Department of Chemistry, University of Canterbury, Christchurch, New Zealand e Department of Pathology, University of Otago, Christchurch, New Zealand f Respiratory Institute, Cleveland Clinic, Cleveland, Ohio, USA |
| |
Abstract: | The analysis of volatile biomarkers of disease in breath is attractive because breath analysis is non-invasive and quick, and allows for repeated sampling. Challenges faced in the development of breath analysis include developing techniques that can measure analytes at very low concentrations, gaining an understanding of the exhalation physiology of individual volatiles, and determining the relationship between the proposed biomarker and the underlying condition. A small number of breath tests are used in clinical practice, but there is great potential for the development and wider application of clinical breath analysis in infection, inflammation, cancer and metabolic disease. |
| |
Keywords: | Biological marker Breath analysis Breath test Electronic nose Exhaled nitric oxide GC-MS PTR-MS Sensor array SIFT-MS Volatile organic compound |
本文献已被 ScienceDirect 等数据库收录! |
|